Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  WebMD Health Corp.    WBMD

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data

Warning: Division by zero in /var/www/surperformance/www.zonebourse.com/include/charts/reuters/ReutersTable.inc.php on line 502
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Sales470515580629681722
Operating income (EBITDA)28,284,3159187209231
Operating profit (EBIT)-0,1757,796,3122139154
Pre-Tax Profit (EBT)-25,228,8----
Net income-20,315,142,161,072,2-
PER ---28,427,2-
EPS ( $)-0,400,311,001,391,46-
Dividend per Share ( $)------
Yield------
Announcement Date02/21/2013
09:00pm
02/20/2014
09:00pm
02/24/2015
09:00pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201220132014201520162017
Debt-12724516662,0-
Finance192----41,8
Operating income (EBITDA)28,284,3159187209231
Leverage
(Debt/EBITDA)
-1,51x1,55x0,89x0,30x-
Capital Expenditure35,2-23,238,732,429,6
Book Value Per Share (BVPS)10,4 $4,25 $----
Cash Flow per Share------
Announcement Date02/21/2013
09:00pm
02/20/2014
09:00pm
02/24/2015
09:00pm
---
Assessed data source :
© 2015 Thomson Reuters
Advertisement
Financial Ratios

Size 2015e 2016e
Capitalization 1 503 M$ -
Entreprise Value (EV) 1 668 M$ 1 565 M$
Valuation 2015e 2016e
PER (Price / EPS) 28,4x 27,2x
Capitalization / Revenue 2,39x 2,21x
EV / Revenue 2,65x 2,30x
EV / EBITDA 8,92x 7,50x
Yield (DPS / Price) - -
Price to book (Price / BVPS) - -
Profitability 2015e 2016e
Operating Margin (EBIT / Sales) 19,4% 20,4%
operating Leverage (Delta EBIT / Delta Sales) 3,18x 1,69x
Net Margin (Net Profit / Revenue) 9,70% 10,6%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2015e 2016e
CAPEX / Sales   6,15% 4,75%
Cash Flow / Sales (Taux d'autofinancement) - -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 0,89x 0,30x
Price Earning Ratio
EPS & Dividend